Bioprocess Validation Market: By Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), By Process Component (Filter Element, Bioreactors), By End-User (CDMO, Biotechnology & Pharmaceutical Companies) and Geography.  

Purchase Option

$ 4400
$ 6600
$ 8900

Bioprocess Validation Market size was valued USD 265.15 million in 2022 and expected to reach USD 410.80 million by 2029, at a CAGR of 5.6% from 2023 to 2029. Bioprocess validation involves several different activities carried out in testing for maintaining the preferred compliance level at all stages. Under bioprocess validation, assessment of active pharmaceutical elements and some contaminants like endotoxin, mycoplasma, and bacteria needs to be done. Specifically, first data is collected, assessed and afterward documented from each stage of a particular project at all the crucial levels. By working this way, bioprocess validation gives scientific proof about its capability of constantly bringing quality products. Consequently efficient process validation greatly contributes in increasing the efficacy, quality and safety of the drug. This market report is a thorough analysis of the medical industry along with providing global market trend analysis. The goal of this market report is to present the overview of the market by doing thorough market categorization on the basis of geography, process component, test and end user. It further gives information about prominent key players operating in the bioprocess validation market along with their place in the market. This report also depicts a few key trends as well as opportunities available in the market.

Bioprocess Validation Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.6%

Largest Market

Asia-Pacific

Fastest Growing Market

Europe
Bioprocess Validation Market Dynamics

Quality and stringent safety rules administering testing and product certification in the health related industries and increasing demand for bioprocess validation services outsourcing are two major factors to drive the market growth. Filter elements section is evaluated to record increasing demand during the forecast period because of the huge use of several different filters in bioprocess. These filters work greatly and increase the safety as well as efficacy of biopharmaceutical products, which serve as the prominent market driving segment.

Bioprocess Validation Market Segmentation

By Test Type
  • Extractables and Leachables
  • Integrity Testing
  • Microbiology Testing
By Process Component
  • Filter Element
  • Bioreactors
By End User
  • CDMO
  • Biotechnology & Pharmaceutical Companies

Frequently Asked Questions

The bioprocess validation market size was valued at USD 265.15 million in 2022.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The bioprocess validation market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Bioprocess Validation Market Introduction 
2.1.Global Bioprocess Validation Market  - Taxonomy
2.2.Global Bioprocess Validation Market  - Definitions
2.2.1.Test Type
2.2.2.Process Component
2.2.3.End User
2.2.4.Region
3. Global Bioprocess Validation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Bioprocess Validation Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Bioprocess Validation Market  By Test Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Extractables and Leachables
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Integrity Testing
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Microbiology Testing
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Bioprocess Validation Market  By Process Component, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Filter Element
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Bioreactors
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Global Bioprocess Validation Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. CDMO
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Biotechnology & Pharmaceutical Companies
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8. Global Bioprocess Validation Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Bioprocess Validation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Extractables and Leachables
9.1.2.Integrity Testing
9.1.3.Microbiology Testing
9.2.  Process Component Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Filter Element
9.2.2.Bioreactors
9.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.CDMO
9.3.2.Biotechnology & Pharmaceutical Companies
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Bioprocess Validation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Extractables and Leachables
10.1.2.Integrity Testing
10.1.3.Microbiology Testing
10.2.  Process Component Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Filter Element
10.2.2.Bioreactors
10.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.CDMO
10.3.2.Biotechnology & Pharmaceutical Companies
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Bioprocess Validation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Extractables and Leachables
11.1.2.Integrity Testing
11.1.3.Microbiology Testing
11.2.  Process Component Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Filter Element
11.2.2.Bioreactors
11.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.CDMO
11.3.2.Biotechnology & Pharmaceutical Companies
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Bioprocess Validation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Extractables and Leachables
12.1.2.Integrity Testing
12.1.3.Microbiology Testing
12.2.  Process Component Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Filter Element
12.2.2.Bioreactors
12.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.CDMO
12.3.2.Biotechnology & Pharmaceutical Companies
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Bioprocess Validation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Extractables and Leachables
13.1.2.Integrity Testing
13.1.3.Microbiology Testing
13.2.  Process Component Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Filter Element
13.2.2.Bioreactors
13.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.CDMO
13.3.2.Biotechnology & Pharmaceutical Companies
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1. Pall Corporation (A Part of Danaher Corporation)
14.2.2. Meissner Filtration Products, Inc.
14.2.3. Merck KGaA
14.2.4. SGS S.A.
14.2.5. Sartorius Stedim Biotech S.A.
14.2.6. Doc S.R.L.
14.2.7. Eurofins Scientific
14.2.8. Cobetter Filtration Equipment Co., Ltd.
14.2.9. Toxikon Corporation
15. Research Methodology 
16. Appendix and Abbreviations 
  • Pall Corporation (A Part of Danaher Corporation)
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • SGS S.A.
  • Sartorius Stedim Biotech S.A.
  • Doc S.R.L.
  • Eurofins Scientific
  • Cobetter Filtration Equipment Co., Ltd.
  • Toxikon Corporation

Adjacent Markets